Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/2748
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLong, D.en
dc.contributor.authorLee-Archer, P. F.en
dc.contributor.authorvon Ungern-Sternberg, B. S.en
dc.contributor.authorReade, M.en
dc.contributor.authorBetts, M.en
dc.contributor.authorHaenke, D.en
dc.contributor.authorKeys, A.en
dc.contributor.authorRance, T.en
dc.contributor.authorGibbons, K.en
dc.date.accessioned2022-11-07T23:34:48Z-
dc.date.available2022-11-07T23:34:48Z-
dc.date.issued2020en
dc.identifier.citation75, (11), 2020, p. 1461-1468en
dc.identifier.otherRISen
dc.identifier.urihttp://dora.health.qld.gov.au/qldresearchjspui/handle/1/2748-
dc.description.abstractChildren may develop changes in their behaviour following general anaesthesia. Some examples of negative behaviour include temper tantrums and nightmares, as well as sleep and eating disorders. The aim of this study was to determine whether dexmedetomidine reduces the incidence of negative behaviour change after anaesthesia for day case surgery in children aged two to seven years. Children were randomly allocated to one of three groups: a premedication group received 2 mg.kg-1 intranasal dexmedetomidine; an intra-operative group received 1 mg.kg-1 intravenous dexmedetomidine; and a control group. The primary outcome was the incidence of negative behaviour on postoperative day 3 using the Post-Hospitalisation Behaviour Questionnaire for Ambulatory Surgery (PHBQ-AS) and the Strength and Difficulties Questionnaire (SDQ). Secondary outcomes included: the incidence of negative behaviour on postoperative days 14 and 28; anxiety at induction; emergence delirium; pain; length of recovery and hospital stay; and any adverse events. The data for 247 patients were analysed. Negative behaviour change on postoperative day 3 was similar between all three groups when measured with the PHBQ-AS (47%, 44% and 51% respectively; adjusted p=0.99) and the SDQ (median scores 7.5, 6.0 and 8.0 respectively; adjusted p=0.99). The incidence of negative behaviour in the group who received dexmedetomidine intra-operatively was less at postoperative day 28 (15% compared with 36% in the dexmedetomidine premedication group and 41% in the control group, p<0.001). We conclude that dexmedetomidine does not reduce the incidence of negative behaviour on postoperative day 3 in two to seven-year olds having day case procedures.L20052161702020-06-30 <br />2021-03-11 <br />en
dc.language.isoenen
dc.relation.ispartofAnaesthesiaen
dc.titleThe effect of dexmedetomidine on postoperative behaviour change in children: a randomised controlled trialen
dc.typeArticleen
dc.identifier.doi10.1111/anae.15117en
dc.subject.keywordsgeneral anesthesiaen
dc.subject.keywordsheart rateen
dc.subject.keywordshospitalizationen
dc.subject.keywordshumanen
dc.subject.keywordshypertensionen
dc.subject.keywordshypotensionen
dc.subject.keywordsintraoperative perioden
dc.subject.keywordslength of stayen
dc.subject.keywordsmajor clinical studyen
dc.subject.keywordsmaleen
dc.subject.keywordsnightmareen
dc.subject.keywordsoutcome assessmenten
dc.subject.keywordspediatric surgeryen
dc.subject.keywordsPost Hospitalisation Behaviour Questionnaire for Ambulatory Surgeryen
dc.subject.keywordspostoperative analgesiaen
dc.subject.keywordspostoperative painen
dc.subject.keywordspostoperative perioden
dc.subject.keywordspremedicationen
dc.subject.keywordsproblem behavioren
dc.subject.keywordsquestionnaireen
dc.subject.keywordsrandomized controlled trialen
dc.subject.keywordsrisk reductionen
dc.subject.keywordsscoring systemen
dc.subject.keywordsside effecten
dc.subject.keywordsstrengthen
dc.subject.keywordsprecedexen
dc.subject.keywordssurgical techniqueen
dc.subject.keywordsdexmedetomidinefentanylen
dc.subject.keywordsmorphineen
dc.subject.keywordsnonsteroid antiinflammatory agenten
dc.subject.keywordsparacetamolen
dc.subject.keywordstramadolen
dc.subject.keywordsambulatory surgeryen
dc.subject.keywordsanesthesia inductionen
dc.subject.keywordsangeren
dc.subject.keywordsanxiety disorderen
dc.subject.keywordsarticleen
dc.subject.keywordsassessment of humansen
dc.subject.keywordsbehavior changeen
dc.subject.keywordschilden
dc.subject.keywordschild behavioren
dc.subject.keywordscontrolled studyen
dc.subject.keywordsconvalescenceen
dc.subject.keywordsdrug bioavailabilityen
dc.subject.keywordsdrug efficacyen
dc.subject.keywordsdrug safetyen
dc.subject.keywordsemergence agitationen
dc.subject.keywordsfemaleen
dc.relation.urlhttps://www.embase.com/search/results?subaction=viewrecord&id=L2005216170&from=exporthttp://dx.doi.org/10.1111/anae.15117 |en
dc.identifier.risid1230en
dc.description.pages1461-1468en
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.openairetypeArticle-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
Appears in Sites:Children's Health Queensland Publications
Queensland Health Publications
Show simple item record

Page view(s)

68
checked on May 8, 2025

Google ScholarTM

Check

Altmetric


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.